U Lindström1, S Exarchou2, V Sigurdardottir3, B Sundström4, J Askling5,6, J K Eriksson5, H Forsblad-d'Elia1, C Turesson2, L E Kristensen2,7, L Jacobsson1. 1. a Department of Rheumatology and Inflammation Research , Sahlgrenska Academy at the University of Gothenburg , Gothenburg. 2. b Section of Rheumatology, Department of Clinical Sciences , Lund University , Malmö 3. c Department of Rheumatology , Falun , Hospital , Falun. 4. d Department of Public Health and Clinical Medicine , Rheumatology, Umeå University , Umeå 5. e Clinical Epidemiology Unit, Department of Medicine Solna , Karolinska Institutet , Stockholm , Sweden. 6. f Rheumatology Unit, Department of Medicine Solna , Karolinska Institutet , Stockholm , Sweden. 7. g The Parker Institute, Department of Rheumatology; Copenhagen University Hospital , Frederiksberg , Denmark.
Abstract
OBJECTIVES: Epidemiological studies of spondyloarthritis (SpA), using ICD codes from the Swedish National Patient Register (NPR), offer unique possibilities but hinge upon an understanding of the validity of the codes. The aim of this study was to validate the ICD codes for ankylosing spondylitis (AS) and undifferentiated SpA (uSpA) in the NPR against the established classification criteria [modified New York (mNY), Assessment of SpondyloArthritis international Society (ASAS), Amor, and European Spondyloarthropathy Study Group (ESSG) criteria]. METHOD: All patients with an ICD-8/9/10 code of AS or uSpA in the NPR 1966-2009 at a visit to a specialist in rheumatology or internal medicine or corresponding hospitalization, alive and living in Sweden 2009, were identified (n=20,089). Following a structured procedure to achieve geographical representativeness, 500 random patients with a diagnosis of AS or uSpA in 2007-2009 were selected. Based on a structured review of clinical records, positive predictive values (PPVs) for fulfilling the criteria sets were calculated. RESULTS: For those having received an ICD code for AS, the PPVs for fulfilling the mNY criteria or any set of SpA criteria were 70% and 89%, respectively. For those with an uSpA diagnosis (and never an AS diagnosis), the corresponding PPVs were 20% and 79%. The subset with both AS and uSpA diagnoses (overlap=12%) were as likely to fulfil the mNY criteria as the group that had been coded as AS only. CONCLUSIONS: The diagnosis codes for AS or uSpA had high PPVs, suggesting that our case identification in the Swedish NPR can be used for nationwide, population-based, epidemiological studies of these diseases.
OBJECTIVES: Epidemiological studies of spondyloarthritis (SpA), using ICD codes from the Swedish National Patient Register (NPR), offer unique possibilities but hinge upon an understanding of the validity of the codes. The aim of this study was to validate the ICD codes for ankylosing spondylitis (AS) and undifferentiated SpA (uSpA) in the NPR against the established classification criteria [modified New York (mNY), Assessment of SpondyloArthritis international Society (ASAS), Amor, and European Spondyloarthropathy Study Group (ESSG) criteria]. METHOD: All patients with an ICD-8/9/10 code of AS or uSpA in the NPR 1966-2009 at a visit to a specialist in rheumatology or internal medicine or corresponding hospitalization, alive and living in Sweden 2009, were identified (n=20,089). Following a structured procedure to achieve geographical representativeness, 500 random patients with a diagnosis of AS or uSpA in 2007-2009 were selected. Based on a structured review of clinical records, positive predictive values (PPVs) for fulfilling the criteria sets were calculated. RESULTS: For those having received an ICD code for AS, the PPVs for fulfilling the mNY criteria or any set of SpA criteria were 70% and 89%, respectively. For those with an uSpA diagnosis (and never an AS diagnosis), the corresponding PPVs were 20% and 79%. The subset with both AS and uSpA diagnoses (overlap=12%) were as likely to fulfil the mNY criteria as the group that had been coded as AS only. CONCLUSIONS: The diagnosis codes for AS or uSpA had high PPVs, suggesting that our case identification in the Swedish NPR can be used for nationwide, population-based, epidemiological studies of these diseases.
Authors: Lars E Bartels; Alma B Pedersen; Nickolaj R Kristensen; Hendrik Vilstrup; Kristian Stengaard-Pedersen; Jens F Dahlerup Journal: Rheumatol Int Date: 2019-12-04 Impact factor: 2.631
Authors: Sizheng Steven Zhao; Joerg Ermann; Chang Xu; Houchen Lyu; Sara K Tedeschi; Katherine P Liao; Kazuki Yoshida; Robert J Moots; Nicola J Goodson; Daniel H Solomon Journal: Rheumatology (Oxford) Date: 2019-11-01 Impact factor: 7.580
Authors: Maureen Dubreuil; Christine Peloquin; Yuqing Zhang; Hyon K Choi; Robert D Inman; Tuhina Neogi Journal: Pharmacoepidemiol Drug Saf Date: 2016-01-13 Impact factor: 2.890
Authors: Amani F Hamad; Viktoriya Vasylkiv; Lin Yan; Ridwan Sanusi; Olawale Ayilara; Joseph A Delaney; Elizabeth Wall-Wieler; Mohammad Jafari Jozani; Pingzhao Hu; Shantanu Banerji; Lisa M Lix Journal: Int J Popul Data Sci Date: 2021-04-15
Authors: Sofia Exarchou; Ulf Lindström; Johan Askling; Jonas K Eriksson; Helena Forsblad-d'Elia; Martin Neovius; Carl Turesson; Lars Erik Kristensen; Lennart T H Jacobsson Journal: Arthritis Res Ther Date: 2015-05-09 Impact factor: 5.156
Authors: Ulf Lindström; Ann Bremander; Emma Haglund; Stefan Bergman; Ingemar F Petersson; Lennart T H Jacobsson Journal: BMC Musculoskelet Disord Date: 2016-02-27 Impact factor: 2.362
Authors: Ulf Lindström; Helena Forsblad-d'Elia; Johan Askling; Lars Erik Kristensen; Elisabeth Lie; Sofia Exarchou; Lennart Jacobsson Journal: Arthritis Res Ther Date: 2016-01-19 Impact factor: 5.156
Authors: Ulf Lindström; Sofia Exarchou; Elisabeth Lie; Mats Dehlin; Helena Forsblad-d'Elia; Johan Askling; Lennart Jacobsson Journal: Arthritis Res Ther Date: 2016-10-22 Impact factor: 5.156
Authors: Karin Bengtsson; Helena Forsblad-d'Elia; Anna Deminger; Eva Klingberg; Mats Dehlin; Sofia Exarchou; Ulf Lindström; Johan Askling; Lennart T H Jacobsson Journal: Rheumatology (Oxford) Date: 2021-06-18 Impact factor: 7.580